113 related articles for article (PubMed ID: 23951246)
21. Regulation of antral follicular growth by an interplay between gonadotropins and their receptors.
Casarini L; Paradiso E; Lazzaretti C; D'Alessandro S; Roy N; Mascolo E; Zaręba K; García-Gasca A; Simoni M
J Assist Reprod Genet; 2022 Apr; 39(4):893-904. PubMed ID: 35292926
[TBL] [Abstract][Full Text] [Related]
22. Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers.
Masi M; Racchi M; Travelli C; Corsini E; Buoso E
Cells; 2021 Nov; 10(11):. PubMed ID: 34831222
[TBL] [Abstract][Full Text] [Related]
23. Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.
Vogelsang TLR; Vattai A; Schmoeckel E; Kaltofen T; Chelariu-Raicu A; Zheng M; Mahner S; Mayr D; Jeschke U; Trillsch F
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445181
[TBL] [Abstract][Full Text] [Related]
24. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
[TBL] [Abstract][Full Text] [Related]
25. G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients.
Fraungruber P; Kaltofen T; Heublein S; Kuhn C; Mayr D; Burges A; Mahner S; Rathert P; Jeschke U; Trillsch F
Front Endocrinol (Lausanne); 2021; 12():564002. PubMed ID: 33679613
[TBL] [Abstract][Full Text] [Related]
26. Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival.
Casarini L; Lazzaretti C; Paradiso E; Limoncella S; Riccetti L; Sperduti S; Melli B; Marcozzi S; Anzivino C; Sayers NS; Czapinski J; Brigante G; Potì F; La Marca A; De Pascali F; Reiter E; Falbo A; Daolio J; Villani MT; Lispi M; Orlando G; Klinger FG; Fanelli F; Rivero-Müller A; Hanyaloglu AC; Simoni M
iScience; 2020 Dec; 23(12):101812. PubMed ID: 33299978
[TBL] [Abstract][Full Text] [Related]
27. β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation.
Czogalla B; Partenheimer A; Jeschke U; von Schönfeldt V; Mayr D; Mahner S; Burges A; Simoni M; Melli B; Benevelli R; Bertini S; Casarini L; Trillsch F
Front Endocrinol (Lausanne); 2020; 11():554733. PubMed ID: 33042017
[TBL] [Abstract][Full Text] [Related]
28. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115
[TBL] [Abstract][Full Text] [Related]
29. Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
Ditsch N; Heublein S; Jeschke U; Sattler C; Kuhn C; Hester A; Czogalla B; Trillsch F; Mahner S; Engel J; Mayr D; Schmoeckel E
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1923-1932. PubMed ID: 32533406
[TBL] [Abstract][Full Text] [Related]
30. G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer.
Xu S; Yu S; Dong D; Lee LTO
Front Endocrinol (Lausanne); 2019; 10():725. PubMed ID: 31708873
[TBL] [Abstract][Full Text] [Related]
31. G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules.
Predescu DV; Crețoiu SM; Crețoiu D; Pavelescu LA; Suciu N; Radu BM; Voinea SC
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703453
[TBL] [Abstract][Full Text] [Related]
32. Role of G Protein-Coupled Estrogen Receptor in Cancer Progression.
Jung J
Toxicol Res; 2019 Jul; 35(3):209-214. PubMed ID: 31341549
[TBL] [Abstract][Full Text] [Related]
33. Extracapsular Lymph Node Involvement in Ovarian Carcinoma.
Heublein S; Schulz H; Marmé F; Angele M; Czogalla B; Burges A; Mahner S; Mayr D; Jeschke U; Schmoeckel E
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31266250
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Tian S; Zhan N; Li R; Dong W
Med Sci Monit; 2019 Apr; 25():3115-3126. PubMed ID: 31028714
[TBL] [Abstract][Full Text] [Related]
35. Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer.
Heublein S; Page S; Mayr D; Schmoeckel E; Trillsch F; Marmé F; Mahner S; Jeschke U; Vattai A
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642093
[TBL] [Abstract][Full Text] [Related]
36. The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.
Friese K; Kost B; Vattai A; Marmé F; Kuhn C; Mahner S; Dannecker C; Jeschke U; Heublein S
J Cancer Res Clin Oncol; 2018 Jan; 144(1):13-19. PubMed ID: 28924735
[TBL] [Abstract][Full Text] [Related]
37. The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression.
Zhang Q; Madden NE; Wong AST; Chow BKC; Lee LTO
Front Endocrinol (Lausanne); 2017; 8():66. PubMed ID: 28439256
[TBL] [Abstract][Full Text] [Related]
38. Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations.
Voutsadakis IA
Clin Med Insights Oncol; 2016; 10():17-25. PubMed ID: 27053923
[TBL] [Abstract][Full Text] [Related]
39. p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer.
Heublein S; Page SK; Mayr D; Ditsch N; Jeschke U
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1163-70. PubMed ID: 26935926
[TBL] [Abstract][Full Text] [Related]
40. Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.
Heublein S; Mayr D; Meindl A; Angele M; Gallwas J; Jeschke U; Ditsch N
PLoS One; 2015; 10(6):e0127072. PubMed ID: 26029931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
